argenx SE ( ARGX) - Stock Earnings
ARGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 344.3 million USD | 1.1 billion USD |
| 2025Q4 | 874.9 million USD | 2.4 billion USD |
| 2026Q1 | 366.0 million USD | 1.3 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q4 Est. | — | — |
ARGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -295.1 million USD | 1.2 billion USD |
| 2024 | 833.0 million USD | 2.2 billion USD |
| 2025 | 1.3 billion USD | 4.2 billion USD |
| 2026 Est. | — | — |
ARGX
Price: $842.27
52 week price:
Earnings Per Share: 22.54 USD
P/E Ratio: 36.08
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 205974
Ebitda: -24.6 millionMarket Capitalization: 52.1 billion